RVMD fund manager activity
Revolution Medicines, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q3 2025 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | Added | 12,500 | $2,341,000 | 0.00% | Aug 14, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | Added | 399,587 | $74,835,000 | 1.72% | Aug 14, 2026 |
| Ken Fisher - Fisher Asset Management | Trimmed | 207,693 | $38,896,915 | 0.01% | Aug 4, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 120,702 | $22,605,071 | 0.05% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | New | 2,500 | $243,125 | 0.00% | May 15, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | New | 315,860 | $30,717,000 | 1.05% | May 15, 2026 |
| Ken Fisher - Fisher Asset Management | Trimmed | 215,947 | $21,000,928 | 0.01% | May 5, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 125,901 | $12,243,872 | 0.04% | May 15, 2026 |
Older quarters